Clinical Trial Update: Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update describes autologous stem cell transplant followed by polatuzumab vedotin for patients with various B-cell non-Hodgkin lymphom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Hodgkin Lymphoma
• Mantle Cell Lymphoma
• Marginal Zone Lymphoma
• Richter Syndrome
• Transformed Non-hodgkin Lymphoma

Drugs mentioned

• Polivy (polatuzumab vedotin)

Snippet

Sponsor: New York Medical College | Conditions: B-cell Lymphoma, Burkitt Lymphoma | Phase 1, Phase 2 | Status: RECRUITING